UnitedHealth Group Incorporated Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
UnitedHealth Group Incorporated (UNH) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $5.65 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-10
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $5.65B, a 58.99% increase year-over-year.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $6.45B, a 0.11% increase year-over-year.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-31 was $223.00M, a 96.12% decline year-over-year.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $2.52B, a 59.50% decline year-over-year.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $12.73B, a 15.50% decline from fiscal 2024.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $15.07B, a 34.36% decline from fiscal 2023.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $22.96B, a 11.84% increase from fiscal 2022.
- UnitedHealth Group Incorporated net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $20.53B, a 16.33% increase from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.65B 10-Q · filed 2026-08-10 | $12.10B 10-Q · filed 2026-08-10 | $12.32B derived: sum of 3 quarters · filed 2026-08-10 | $14.84B derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $6.45B 10-Q · filed 2026-05-05 | $6.67B derived: sum of 2 quarters · filed 2026-05-05 | $9.19B derived: sum of 3 quarters · filed 2026-05-05 | $12.74B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $223.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.74B derived: sum of 2 quarters · filed 2026-03-02 | $6.29B derived: sum of 3 quarters · filed 2026-08-10 | $12.73B 10-K · filed 2026-03-02 |
| 2025-09-30 | $2.52B 10-Q · filed 2025-10-28 | $6.07B derived: sum of 2 quarters · filed 2026-08-10 | $12.51B 10-Q · filed 2025-10-28 | $18.25B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $3.56B 10-Q · filed 2026-08-10 | $9.99B 10-Q · filed 2026-08-10 | $15.74B derived: sum of 3 quarters · filed 2026-08-10 | $21.95B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.44B 10-Q · filed 2026-05-05 | $12.18B derived: sum of 2 quarters · filed 2026-05-05 | $18.39B derived: sum of 3 quarters · filed 2026-05-05 | $22.77B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.74B derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $11.95B derived: sum of 2 quarters · filed 2026-03-02 | $16.33B derived: sum of 3 quarters · filed 2026-03-02 | $15.07B 10-K · filed 2026-03-02 |
| 2024-09-30 | $6.21B 10-Q · filed 2025-10-28 | $10.58B derived: sum of 2 quarters · filed 2025-10-28 | $9.32B 10-Q · filed 2025-10-28 | $14.95B derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.37B 10-Q · filed 2025-08-11 | $3.11B 10-Q · filed 2025-08-11 | $8.74B derived: sum of 3 quarters · filed 2026-03-02 | $14.73B derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$1.26B 10-Q · filed 2025-05-07 | $4.37B derived: sum of 2 quarters · filed 2026-03-02 | $10.36B derived: sum of 3 quarters · filed 2026-03-02 | $15.97B derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $5.63B derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $11.62B derived: sum of 2 quarters · filed 2026-03-02 | $17.23B derived: sum of 3 quarters · filed 2026-03-02 | $22.96B 10-K · filed 2026-03-02 |
| 2023-09-30 | $5.99B 10-Q · filed 2024-11-04 | $11.60B derived: sum of 2 quarters · filed 2024-11-04 | $17.33B 10-Q · filed 2024-11-04 | $22.21B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.61B 10-Q · filed 2024-08-09 | $11.34B 10-Q · filed 2024-08-09 | $16.22B derived: sum of 3 quarters · filed 2025-02-27 | $21.58B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.72B 10-Q · filed 2024-05-09 | $10.61B derived: sum of 2 quarters · filed 2025-02-27 | $15.97B derived: sum of 3 quarters · filed 2025-02-27 | $21.14B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.89B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.25B derived: sum of 2 quarters · filed 2025-02-27 | $15.41B derived: sum of 3 quarters · filed 2025-02-27 | $20.53B 10-K · filed 2025-02-27 |
| 2022-09-30 | $5.36B 10-Q · filed 2023-11-06 | $10.53B derived: sum of 2 quarters · filed 2023-11-06 | $15.64B 10-Q · filed 2023-11-06 | $19.82B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $5.16B 10-Q · filed 2023-08-02 | $10.28B 10-Q · filed 2023-08-02 | $14.46B derived: sum of 3 quarters · filed 2024-02-28 | $18.63B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.12B 10-Q · filed 2023-05-03 | $9.29B derived: sum of 2 quarters · filed 2024-02-28 | $13.46B derived: sum of 3 quarters · filed 2024-02-28 | $17.82B derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $4.18B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.35B derived: sum of 2 quarters · filed 2024-02-28 | $12.70B derived: sum of 3 quarters · filed 2024-02-28 | $17.64B 10-K · filed 2024-02-28 |
| 2021-09-30 | $4.17B 10-Q · filed 2022-11-02 | $8.53B derived: sum of 2 quarters · filed 2022-11-02 | $13.47B 10-Q · filed 2022-11-02 | $15.78B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $4.35B 10-Q · filed 2022-08-03 | $9.30B 10-Q · filed 2022-08-03 | $11.60B derived: sum of 3 quarters · filed 2023-02-24 | $14.84B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $4.94B 10-Q · filed 2022-05-04 | $7.25B derived: sum of 2 quarters · filed 2023-02-24 | $10.48B derived: sum of 3 quarters · filed 2023-02-24 | $17.16B derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $2.31B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $5.54B derived: sum of 2 quarters · filed 2023-02-24 | $12.22B derived: sum of 3 quarters · filed 2023-02-24 | $15.66B 10-K · filed 2023-02-24 |
| 2020-09-30 | $3.23B 10-Q · filed 2021-11-03 | $9.91B derived: sum of 2 quarters · filed 2021-11-03 | $13.35B 10-Q · filed 2021-11-03 | $16.98B derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $6.67B 10-Q · filed 2021-08-03 | $10.12B 10-Q · filed 2021-08-03 | $13.75B derived: sum of 3 quarters · filed 2022-02-15 | $17.37B derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $3.44B 10-Q · filed 2021-05-05 | $7.07B derived: sum of 2 quarters · filed 2022-02-15 | $10.69B derived: sum of 3 quarters · filed 2022-02-15 | $14.04B derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $3.63B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $7.25B derived: sum of 2 quarters · filed 2022-02-15 | $10.60B derived: sum of 3 quarters · filed 2022-02-15 | $14.12B 10-K · filed 2022-02-15 |
| 2019-09-30 | $3.62B 10-Q · filed 2020-11-02 | $6.97B derived: sum of 2 quarters · filed 2020-11-02 | $10.49B 10-Q · filed 2020-11-02 | $13.62B derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.35B 10-Q · filed 2020-08-03 | $6.87B 10-Q · filed 2020-08-03 | $10.00B derived: sum of 3 quarters · filed 2021-03-01 | $13.26B derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $3.53B 10-Q · filed 2020-05-06 | $6.66B derived: sum of 2 quarters · filed 2021-03-01 | $9.92B derived: sum of 3 quarters · filed 2021-03-01 | $12.90B derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $3.13B derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $6.39B derived: sum of 2 quarters · filed 2021-03-01 | $9.37B derived: sum of 3 quarters · filed 2021-03-01 | $12.26B 10-K · filed 2021-03-01 |
| 2018-09-30 | $3.26B 10-Q · filed 2019-11-06 | $6.24B derived: sum of 2 quarters · filed 2019-11-06 | $9.13B 10-Q · filed 2019-11-06 | $12.82B derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $2.98B 10-Q · filed 2019-08-07 | $5.87B 10-Q · filed 2019-08-07 | $9.56B derived: sum of 3 quarters · filed 2020-02-14 | $12.10B derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $2.89B 10-Q · filed 2019-05-07 | $6.58B derived: sum of 2 quarters · filed 2020-02-14 | $9.12B derived: sum of 3 quarters · filed 2020-02-14 | $11.46B derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $3.69B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $6.23B derived: sum of 2 quarters · filed 2020-02-14 | $8.57B derived: sum of 3 quarters · filed 2020-02-14 | $10.75B 10-K · filed 2020-02-14 |
| 2017-09-30 | $2.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.88B derived: sum of 2 quarters · filed 2018-11-08 | $7.06B 10-Q · filed 2018-11-08 | $8.75B derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-06-30 | $2.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $4.52B 10-Q · filed 2018-08-07 | $6.21B derived: sum of 3 quarters · filed 2019-02-12 | $8.19B derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-03-31 | $2.18B 10-Q · filed 2018-05-07 | $3.87B derived: sum of 2 quarters · filed 2019-02-12 | $5.85B derived: sum of 3 quarters · filed 2019-02-12 | $7.62B derived: sum of 4 quarters · filed 2019-02-12 |
| 2016-12-31 | $1.69B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-12 | $3.67B derived: sum of 2 quarters · filed 2019-02-12 | $5.43B derived: sum of 3 quarters · filed 2019-02-12 | $7.06B 10-K · filed 2019-02-12 |
| 2016-09-30 | $1.98B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.74B derived: sum of 2 quarters · filed 2017-11-07 | $5.36B 10-Q · filed 2017-11-07 | $6.60B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $1.76B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $3.39B 10-Q · filed 2017-08-04 | $4.62B derived: sum of 3 quarters · filed 2018-02-13 | $6.23B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $1.62B 10-Q · filed 2017-05-08 | $2.85B derived: sum of 2 quarters · filed 2018-02-13 | $4.46B derived: sum of 3 quarters · filed 2018-02-13 | $6.05B derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $2.84B derived: sum of 2 quarters · filed 2018-02-13 | $4.43B derived: sum of 3 quarters · filed 2018-02-13 | $5.84B 10-K · filed 2018-02-13 |
| 2015-09-30 | $1.61B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $3.19B derived: sum of 2 quarters · filed 2016-11-08 | $4.61B 10-Q · filed 2016-11-08 | $6.12B derived: sum of 4 quarters · filed 2017-02-08 |
| 2015-06-30 | $1.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $3.00B 10-Q · filed 2016-08-02 | $4.51B derived: sum of 3 quarters · filed 2017-02-08 | |
| 2015-03-31 | $1.41B 10-Q · filed 2016-05-04 | $2.92B derived: sum of 2 quarters · filed 2017-02-08 | ||
| 2014-12-31 | $1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-08 | $5.62B 10-K · filed 2017-02-08 | ||
| 2014-09-30 | $4.11B 10-Q · filed 2015-11-05 | |||
| 2013-12-31 | $5.63B 10-K · filed 2016-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B |